IMMVAC: Superior Science

The IMMVAC INC. products are based on two proprietary technologies in a single vaccine.

Core Antigen

The patented, genetically-engineered Gram-negative bacterin is comprised of the universal core antigen common to all Gram-negative bacteria.

IMMUNE Plus®

The patented IMMUNE Plus® stimulates production of B and T lymphocytes, thereby enhancing an animals overall immunity to disease.